Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings—Implications for intervention impact
Wedi'i Gadw mewn:
Vickerman, P., ET AL., Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings—Implications for intervention impact. Drug and Alcohol Dependence, Vol. 123, no. 1-3 (2012), p. 122-131.
Ref.
186638
Lleoliad:
SIIS R.854 Archivo
Palabras clave:
Discapacidad, Drogas ilegales, Drogodependencias, Efectos, Enfermos, Epidemiología, Factor de riesgo, Hepatitis, Sida, Tendencias, Vía intravenosa
Discapacidad, Drogas ilegales, Drogodependencias, Efectos, Enfermos, Epidemiología, Factor de riesgo, Hepatitis, Sida, Tendencias, Vía intravenosa
Eitemau Tebyg: Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings—Implications for intervention impact
- THE AUSTRALIAN STUDY OF HIV AND INJECTING DRUG USE. PART I: PREVALENCE FOR HIV, HEPATITIS B AND HEPATITIS C AMONG INJECTING DRUG USERS IN FOUR AUSTRALIAN CITIES
- HEPATITIS C AND HIV INFECTIONS: IMPLICATIONS FOR CLINICAL CARE IN INJECTION DRUG USERS
- INJECTING DRUG USERS' UNDERSTANDING OF HEPATITIS C
- CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS
- PREVALENCE OF MARKERS FOR HEPATITIS B VIRUS AND HIV-1 AMONG DRUG INJECTORS IN LONDON: INJECTING CAREERS, POSITIVITY AND RISK BEHAVIOUR
- SIGNIFICANT REDUCTIONS OF HIV PREVALENCE BUT NOT OF HEPATITIS C VIRUS INFECTIONS IN INJECTION DRUG USERS FROM METROPOLITAN BARCELONA: 1987-2001